The legacy status of Viagra, and the parent company copyright, presents a complex question for investors . While revenues initially soared , the impending patent expiry and growing generic rivalry represent https://deborahcgrj671638.blogrelation.com/48140158/copyright-s-blockbuster-and-pharma-a-risky-investment